Advertisement

Bendamustine

  • Ines Mader
  • Patrizia E. Fürst-Weger
  • Robert M. Mader
  • Elisabeth I. Semenitz
  • Robert Terkola
  • Sabine M. Wassertheurer

Keywords

Public Health Internal Medicine Specific Measure Product Characteristic General Measure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Original articles

  1. [1]
    Ruffert K, Jahn H, Syrbe G, et al: Cytostasan® (Bendamustin) in der Alternativtherapie maligner Non-Hodgkin-Lymphome — Cytostasan (bendamustin) as an alternative therapeutic approach to treat malignant non-Hodgkin’s lymphoma. Z KIM Med 44: 671–674, 1989.Google Scholar
  2. [2]
    Brockmann B, Geschke E, Schmidt UM, et al: Therapieergebnisse und toxische Nebenwirkungen der Kombination Cytostasan, Adriamycin und Vincristin als „Second line“-Therapie beim metastasierten Mammakarzinom. In: Geburtshilfe und Frauenheilkunde. Georg Thieme Verlag 51: 383–386, 1991.Google Scholar

Secondary literature

  1. [3]
    Gain M, Melzer S, Meyer-Jürshof A, et al: Bendamustin: Behandlung von Paravasaten. In: Gain M, et al (eds) ADKA-Zytostatika-Handbuch. Verlag Heiner Biller, Vol 4: 24, 2000.Google Scholar
  2. [4]
    Sauer H: Substanzprofile, Zytostatika, Hormone, Zytokine: Bendamustin. In: Schmoll HJ, Höffken K, Possinger K (eds) Kompendium Internistische Onkologie. Standards in Diagnostik und Therapie. Springer, Vol 1, 3rd edition: 736–737, 1999.Google Scholar
  3. [5]
    Summary of product characteristics Ribomustin® (Germany), Ribosepharm, July 1998.Google Scholar
  4. [6]
    Information for hospital pharmacists Ribomustin® (Germany), Ribosepharm, October 1998.Google Scholar

Copyright information

© Springer-Verlag Wien 2003

Authors and Affiliations

  • Ines Mader
    • 1
  • Patrizia E. Fürst-Weger
    • 2
  • Robert M. Mader
    • 3
  • Elisabeth I. Semenitz
    • 4
  • Robert Terkola
    • 5
  • Sabine M. Wassertheurer
    • 6
  1. 1.Austrian Breast and Colorectal Cancer Study GroupViennaAustria
  2. 2.SMZ FloridsdorfKrankenhaus und GeriatriezentrumViennaAustria
  3. 3.Clinical Division of Oncology, Department of Medicine IUniversity HospitalViennaAustria
  4. 4.AnstaltsapothekeLandeskrankenhaus — Universitätskliniken InnsbruckAustria
  5. 5.Kaiser-Franz-Josef HospitalViennaAustria
  6. 6.Apotheke LKH-Univ.-Klinikum GrazAustria

Personalised recommendations